The Board of directors of Tatva Chintan Pharma Chem Ltd [check out the Q4 and year ended financial result details here] have recommended a Final Dividend of ₹2/- (20%) per equity share of ₹10/- each fully paid (subject to deduction of tax, if any) on the equity share capital of ₹ 22,16,50,620/- (2,21,65,062 equity shares of ₹ 10/- each) for the financial year 2021-22. This shall be paid subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company.
Shares of Tatva Chintan Pharma Chem Ltd was last trading in BSE at ₹ 2476.25 as compared to the previous close of ₹ 2496.25. The total number of shares traded during the day was 1712 in over 251 trades.
The stock of Tatva Chintan Pharma Chem last hit in BSE,
- Intraday High of ₹ 2491.00
- Intraday low of ₹ 2458.10